Listing 1 - 10 of 11 | << page >> |
Sort by
|
Choose an application
With a mean worldwide prevalence of 13%, chronic kidney disease imposes a massive health burden on our society. In addition to reduced kidney function, patients with chronic kidney disease increasingly suffer from cardiovascular diseases affecting the heart and vasculature. Cardiovascular diseases account for around half of the deaths of patients with advanced chronic kidney disease. However, therapeutic options are highly insufficient. The pathological mechanisms that underlie increased cardiovascular risk in patients with chronic kidney disease remain largely unknown. This Special Issue provides insights into comorbidities in CKD patients, mainly focused on increased cardiovascular risk, and summarizes current knowledge of underlying pathophysiological mechanisms.
arterial stiffness --- carotid–femoral pulse wave velocity --- hemodialysis --- p-cresyl sulfate --- uremic toxins --- arterial calcification --- lipid metabolism --- inflammation --- coagulation --- endothelial dysfunction --- epigenetics --- chronic kidney disease --- uremic cardiopathy --- left ventricular hypertrophy --- phosphate --- PTH --- FGF23 --- klotho --- sclerostin --- chronodisruption --- chronodisruptor --- circadian rhythm --- internal clock --- uremia --- uremic cardiomyopathy --- organ crosstalk --- cardiorenal syndrome --- left-ventricular hypertrophy --- heart failure --- cardiac fibrosis --- cardiovascular disease --- vascular calcification --- experimental rodent models --- FGFG23 --- Klotho --- Wnt/β-catenin --- CKD --- parathyroid hormone --- secondary hyperparathyroidism --- uremic toxin --- ageing --- end-stage kidney disease --- premature ageing --- senescence --- bone --- gut --- cardiovascular --- CKD–MBD --- comorbidity --- fibrosis --- calcification
Choose an application
With a mean worldwide prevalence of 13%, chronic kidney disease imposes a massive health burden on our society. In addition to reduced kidney function, patients with chronic kidney disease increasingly suffer from cardiovascular diseases affecting the heart and vasculature. Cardiovascular diseases account for around half of the deaths of patients with advanced chronic kidney disease. However, therapeutic options are highly insufficient. The pathological mechanisms that underlie increased cardiovascular risk in patients with chronic kidney disease remain largely unknown. This Special Issue provides insights into comorbidities in CKD patients, mainly focused on increased cardiovascular risk, and summarizes current knowledge of underlying pathophysiological mechanisms.
Medicine --- arterial stiffness --- carotid–femoral pulse wave velocity --- hemodialysis --- p-cresyl sulfate --- uremic toxins --- arterial calcification --- lipid metabolism --- inflammation --- coagulation --- endothelial dysfunction --- epigenetics --- chronic kidney disease --- uremic cardiopathy --- left ventricular hypertrophy --- phosphate --- PTH --- FGF23 --- klotho --- sclerostin --- chronodisruption --- chronodisruptor --- circadian rhythm --- internal clock --- uremia --- uremic cardiomyopathy --- organ crosstalk --- cardiorenal syndrome --- left-ventricular hypertrophy --- heart failure --- cardiac fibrosis --- cardiovascular disease --- vascular calcification --- experimental rodent models --- FGFG23 --- Klotho --- Wnt/β-catenin --- CKD --- parathyroid hormone --- secondary hyperparathyroidism --- uremic toxin --- ageing --- end-stage kidney disease --- premature ageing --- senescence --- bone --- gut --- cardiovascular --- CKD–MBD --- comorbidity --- fibrosis --- calcification --- arterial stiffness --- carotid–femoral pulse wave velocity --- hemodialysis --- p-cresyl sulfate --- uremic toxins --- arterial calcification --- lipid metabolism --- inflammation --- coagulation --- endothelial dysfunction --- epigenetics --- chronic kidney disease --- uremic cardiopathy --- left ventricular hypertrophy --- phosphate --- PTH --- FGF23 --- klotho --- sclerostin --- chronodisruption --- chronodisruptor --- circadian rhythm --- internal clock --- uremia --- uremic cardiomyopathy --- organ crosstalk --- cardiorenal syndrome --- left-ventricular hypertrophy --- heart failure --- cardiac fibrosis --- cardiovascular disease --- vascular calcification --- experimental rodent models --- FGFG23 --- Klotho --- Wnt/β-catenin --- CKD --- parathyroid hormone --- secondary hyperparathyroidism --- uremic toxin --- ageing --- end-stage kidney disease --- premature ageing --- senescence --- bone --- gut --- cardiovascular --- CKD–MBD --- comorbidity --- fibrosis --- calcification
Choose an application
The impact of fat intake on hypercholesterolemia and related atherosclerotic cardiovascular diseases has been studied for decades. However, the current evidence base suggests that fatty acids also influences cardiometabolic diseases through other mechanisms including effects on glucose metabolism, body fat distribution, blood pressure, inflammation, and heart rate. Furthermore, studies evaluating single fatty acids have challenged the simplistic view of shared health effects within fatty acid groups categorized by degree of saturation. In addition, investigations of endogenous fatty acid metabolism, including genetic studies of fatty acid metabolizing enzymes, and the identification of novel metabolically derived fatty acids have further increased the complexity of fatty acids’ health impacts. This Special Issue aims to include original research and up-to-date reviews on genetic and dietary modulation of fatty acids, and the role and function of dietary and metabolically derived fatty acids in cardiometabolic health.
coronary artery disease --- n-6 fatty acids --- ischemic heart disease --- n-3 fatty acids --- body weight --- alternatively activated macrophages --- type 2 cytokines --- children --- medium-chain triglyceride --- fat --- omega-3 PUFA --- substitution models --- obesity --- EETs --- arachidonic acid --- blood pressure --- Genome-wide association study (GWAS) --- antioxidant --- Mediterranean diet --- Insulin sensitivity --- PUFA --- n-3 PUFA --- long-chain triglyceride --- fish oil --- omega 3 --- CAD --- adipose tissue --- FADS --- blood lipids --- hemodynamics --- genotype --- erucic acid --- klotho --- CYP450 eicosanoids --- cardiometabolic disease --- fibrosis --- desaturase --- EEQs --- cohort study --- lipid metabolism --- fatty acid --- metabolic disease --- epidemiology --- omega-3 --- inflammation --- docosapentaenoic acid --- omega-6 PUFA --- type 2 diabetes mellitus --- diet --- CKD --- human --- perivascular adipose tissue --- seafood --- cardiovascular disease --- prospective cohort study --- linoleic acid --- low-fat diet --- conjugated fatty acids --- furan fatty acids --- unsaturated fat --- statins --- fish --- cholesterol ester --- CHD --- COPD
Choose an application
Refrigeration, air conditioning, and heat pumps (RACHP) have an important impact on the final energy uses of many sectors of modern society, such as residential, commercial, industrial, transport, and automotive. Moreover, RACHP also have an important environmental impact due to the working fluids that deplete the stratospheric ozone layer, which are being phased out according to the Montreal Protocol (1989). Last, but not least, high global working potential (GWP), working fluids (directly), and energy consumption (indirectly) are responsible for a non-negligible quota of greenhouse gas (GHG) emissions in the atmosphere, thus impacting climate change.
History of engineering & technology --- burnt-out diabetes --- chronic kidney disease (CKD) --- dialysis --- end-stage renal disease (ESRD) --- incident diabetes mellitus (DM) --- insulin resistance --- dementia --- dipeptidyl-peptidase IV inhibitors --- diabetes mellitus --- type 2 --- Alzheimer’s disease --- vascular --- diabetes --- microperimetry --- type 2 diabetes mellitus --- glucose fluctuations --- sarcopenia --- diabetic retinopathy --- type 1 diabetes --- quality of life --- treatment satisfaction --- patient-reported outcomes --- plaque characteristics --- carotid plaque --- echogenic plaque --- diabetic foot syndrome --- vascular disease --- fibroblast growth factor 23 --- Klotho --- inflammation --- dermal electrochemical conductance --- neuropathy --- primary care --- screening --- sudomotor reflex --- prediabetes --- arterial stiffness --- baPWV --- aspirin --- primary prevention --- meta-analysis --- trial sequential analysis --- sCD36 --- type 1 diabetes mellitus --- branched-chain amino acids --- metabolomics --- NMR spectroscopy --- diabetic kidney disease --- reno-cardiovascular protection --- sodium-glucose co-transporter 2 inhibitors --- glucagon-like peptide-1 receptor agonists --- dipeptidyl peptidase 4 inhibitors --- obesity --- bariatric surgery --- diabetic macroangiopathy --- cardiovascular disease --- heart disease --- cerebrovascular disease --- peripheral artery disease --- diabetic foot disease --- diabetic microangiopathy --- diabetic neuropathy
Choose an application
There is unequivocal experimental, epidemiological, and clinical evidence demonstrating a correlation between diet and increased risk of cardiovascular disease (CVD). While nutritionally-poor diets can have a significant negative impact on cardiovascular health, dietary interventions with specific nutrients and/or functional foods are considered cost-effective and efficient components of prevention strategies. It has been estimated that nutritional factors may be responsible for approximately 40% of all CVD. Indeed, in one of the seminal studies conducted on modifiable risk factors and heart health (the INTERHEART study), >90% of all myocardial infarctions were attributed to preventable environmental factors with nutrition identified as one of the important determinants of CVD. There is an increasing public interest in and scientific investigation into establishing dietary approaches that can be undertaken for the prevention and treatment of CVD. This Special Issue provides an insight into the influential role of nutrition and dietary habits on cardiovascular health and disease, as well as their mechanisms of therapeutic and preventive action.
Research & information: general --- Biology, life sciences --- Food & society --- magnesium deficiency --- arterial hypertension --- vascular tone --- arterial stiffness --- vascular remodeling --- insulin resistance --- magnesium supplementation --- dietary magnesium intake --- Zeb2 --- cardiac fibroblast --- activated myofibroblast --- cardiac fibrosis --- fibroblast contractility --- fish oil --- omega-3 fatty acids --- eicosapentaenoic acid (EPA) --- docosahexaenoic acid (DHA) --- cardiovascular disease --- irisin --- pediatric --- children --- nutrition --- diet --- body composition --- metabolic syndrome --- obesity, neonates --- Mediterranean diet --- inflammation --- nutrients --- polyphenols --- MUFA --- PUFA --- bioactive compounds --- phytosterols --- dietary pattern --- Aronia melanocarpa --- standardized extract --- dietary strategies --- supplementation --- cocaine --- cardiovascular health --- heart disease --- acute effects --- chronic effects --- marinobufagenin --- ouabain --- salt --- hypertension --- fibrosis --- Panax quinquefolius --- ginseng berry --- myocardial infarction --- phenolic compounds --- vascular aging --- vascular calcification --- arteriosclerosis --- Klotho --- chronic kidney disease (CKD), cancer --- diabetes --- heart failure --- micronutrients --- iron --- vitamins --- trace elements --- vitamin D --- seasonal variation --- lifestyle --- cytokines --- lipids --- mechanisms --- immunoregulatory --- eicosapentaenoic acid --- docosahexaenoic acid --- omega-3 polyunsaturated fatty acids --- coronary heart disease --- stretching --- TGF-β1 --- n/a
Choose an application
There is unequivocal experimental, epidemiological, and clinical evidence demonstrating a correlation between diet and increased risk of cardiovascular disease (CVD). While nutritionally-poor diets can have a significant negative impact on cardiovascular health, dietary interventions with specific nutrients and/or functional foods are considered cost-effective and efficient components of prevention strategies. It has been estimated that nutritional factors may be responsible for approximately 40% of all CVD. Indeed, in one of the seminal studies conducted on modifiable risk factors and heart health (the INTERHEART study), >90% of all myocardial infarctions were attributed to preventable environmental factors with nutrition identified as one of the important determinants of CVD. There is an increasing public interest in and scientific investigation into establishing dietary approaches that can be undertaken for the prevention and treatment of CVD. This Special Issue provides an insight into the influential role of nutrition and dietary habits on cardiovascular health and disease, as well as their mechanisms of therapeutic and preventive action.
magnesium deficiency --- arterial hypertension --- vascular tone --- arterial stiffness --- vascular remodeling --- insulin resistance --- magnesium supplementation --- dietary magnesium intake --- Zeb2 --- cardiac fibroblast --- activated myofibroblast --- cardiac fibrosis --- fibroblast contractility --- fish oil --- omega-3 fatty acids --- eicosapentaenoic acid (EPA) --- docosahexaenoic acid (DHA) --- cardiovascular disease --- irisin --- pediatric --- children --- nutrition --- diet --- body composition --- metabolic syndrome --- obesity, neonates --- Mediterranean diet --- inflammation --- nutrients --- polyphenols --- MUFA --- PUFA --- bioactive compounds --- phytosterols --- dietary pattern --- Aronia melanocarpa --- standardized extract --- dietary strategies --- supplementation --- cocaine --- cardiovascular health --- heart disease --- acute effects --- chronic effects --- marinobufagenin --- ouabain --- salt --- hypertension --- fibrosis --- Panax quinquefolius --- ginseng berry --- myocardial infarction --- phenolic compounds --- vascular aging --- vascular calcification --- arteriosclerosis --- Klotho --- chronic kidney disease (CKD), cancer --- diabetes --- heart failure --- micronutrients --- iron --- vitamins --- trace elements --- vitamin D --- seasonal variation --- lifestyle --- cytokines --- lipids --- mechanisms --- immunoregulatory --- eicosapentaenoic acid --- docosahexaenoic acid --- omega-3 polyunsaturated fatty acids --- coronary heart disease --- stretching --- TGF-β1 --- n/a
Choose an application
Refrigeration, air conditioning, and heat pumps (RACHP) have an important impact on the final energy uses of many sectors of modern society, such as residential, commercial, industrial, transport, and automotive. Moreover, RACHP also have an important environmental impact due to the working fluids that deplete the stratospheric ozone layer, which are being phased out according to the Montreal Protocol (1989). Last, but not least, high global working potential (GWP), working fluids (directly), and energy consumption (indirectly) are responsible for a non-negligible quota of greenhouse gas (GHG) emissions in the atmosphere, thus impacting climate change.
burnt-out diabetes --- chronic kidney disease (CKD) --- dialysis --- end-stage renal disease (ESRD) --- incident diabetes mellitus (DM) --- insulin resistance --- dementia --- dipeptidyl-peptidase IV inhibitors --- diabetes mellitus --- type 2 --- Alzheimer’s disease --- vascular --- diabetes --- microperimetry --- type 2 diabetes mellitus --- glucose fluctuations --- sarcopenia --- diabetic retinopathy --- type 1 diabetes --- quality of life --- treatment satisfaction --- patient-reported outcomes --- plaque characteristics --- carotid plaque --- echogenic plaque --- diabetic foot syndrome --- vascular disease --- fibroblast growth factor 23 --- Klotho --- inflammation --- dermal electrochemical conductance --- neuropathy --- primary care --- screening --- sudomotor reflex --- prediabetes --- arterial stiffness --- baPWV --- aspirin --- primary prevention --- meta-analysis --- trial sequential analysis --- sCD36 --- type 1 diabetes mellitus --- branched-chain amino acids --- metabolomics --- NMR spectroscopy --- diabetic kidney disease --- reno-cardiovascular protection --- sodium-glucose co-transporter 2 inhibitors --- glucagon-like peptide-1 receptor agonists --- dipeptidyl peptidase 4 inhibitors --- obesity --- bariatric surgery --- diabetic macroangiopathy --- cardiovascular disease --- heart disease --- cerebrovascular disease --- peripheral artery disease --- diabetic foot disease --- diabetic microangiopathy --- diabetic neuropathy
Choose an application
In recent years, artificial intelligence has increasingly been playing an essential role in diverse areas in medicine, assisting clinicians in patient management. In nephrology and transplantation, artificial intelligence can be utilized to enhance clinical care, such as through hemodialysis prescriptions and the follow-up of kidney transplant patients. Furthermore, there are rapidly expanding applications and validations of comprehensive, computerized medical records and related databases, including national registries, health insurance, and drug prescriptions. For this Special Issue, we made a call to action to stimulate researchers and clinicians to submit their invaluable works and present, here, a collection of articles covering original clinical research (single- or multi-center), database studies from registries, meta-analyses, and artificial intelligence research in nephrology including acute kidney injury, electrolytes and acid–base, chronic kidney disease, glomerular disease, dialysis, and transplantation that will provide additional knowledge and skills in the field of nephrology and transplantation toward improving patient outcomes.
Medicine --- tacrolimus --- C/D ratio --- tacrolimus metabolism --- everolimus --- conversion --- kidney transplantation --- gut microbiome --- renal transplant recipient --- diarrhea --- immunosuppressive medication --- gut microbiota --- 16S rRNA sequencing --- butyrate-producing bacteria --- Proteobacteria --- torquetenovirus --- immunosuppression --- transplantation --- immunosuppressed host --- outcome --- renal transplantation --- Goodpasture syndrome --- anti-GBM disease --- epidemiology --- hospitalization --- outcomes --- acute kidney injury --- risk prediction --- artificial intelligence --- patent ductus arteriosus --- conservative management --- blood pressure --- eradication --- interferon-free regimen --- hepatitis C infection --- kidney transplant --- allograft steatosis --- lipopeliosis --- transplant numbers --- live donors --- public awareness --- Google TrendsTM --- machine learning --- big data --- nephrology --- chronic kidney disease --- NLR --- PLR --- RPGN --- predictive value --- hemodialysis --- withdrawal --- cellular crescent --- global sclerosis --- procurement kidney biopsy --- glomerulosclerosis --- minimally-invasive donor nephrectomy --- robot-assisted surgery --- laparoscopic surgery --- organ donation --- living kidney donation --- MeltDose® --- LCPT --- renal function --- liver transplantation --- metabolism --- erythropoietin --- fibroblast growth factor 23 --- death --- weekend effect --- in-hospital mortality --- comorbidity --- dialysis --- elderly --- klotho --- α-Klotho --- FGF-23 --- kidney donor --- Nephrology --- CKD-MBD --- CKD-Mineral and Bone Disorder --- deceased donor --- Eurotransplant Senior Program --- risk stratification --- intensive care --- kidney transplant recipients --- long-term outcomes --- graft failure --- cardiovascular mortality --- lifestyle --- inflammation --- vascular calcification --- bone mineral density --- dual-energy X-ray absorptiometry --- living donation --- repeated kidney transplantation --- graft survival --- prolonged ischaemic time --- patient survival --- pre-emptive transplantation --- metabolomics --- urine --- acute rejection --- allograft --- cystatin C --- hyperfiltration --- kidney injury molecule (KIM)-1 --- tubular damage --- genetic polymorphisms --- (cardiac) surgery --- inflammatory cytokines --- clinical studies --- chronic kidney disease (CKD) --- no known kidney disease (NKD) --- ICD-10 billing codes --- phenotyping --- electronic health record (EHR) --- estimated glomerular filtration rate (eGFR) --- machine learning (ML) --- generalized linear model network (GLMnet) --- random forest (RF) --- artificial neural network (ANN), clinical natural language processing (clinical NLP) --- discharge summaries --- laboratory values --- area under the receiver operating characteristic (AUROC) --- area under the precision-recall curve (AUCPR) --- fibrosis --- extracellular matrix --- collagen type VI --- living-donor kidney transplantation --- ethnic disparity --- tacrolimus --- C/D ratio --- tacrolimus metabolism --- everolimus --- conversion --- kidney transplantation --- gut microbiome --- renal transplant recipient --- diarrhea --- immunosuppressive medication --- gut microbiota --- 16S rRNA sequencing --- butyrate-producing bacteria --- Proteobacteria --- torquetenovirus --- immunosuppression --- transplantation --- immunosuppressed host --- outcome --- renal transplantation --- Goodpasture syndrome --- anti-GBM disease --- epidemiology --- hospitalization --- outcomes --- acute kidney injury --- risk prediction --- artificial intelligence --- patent ductus arteriosus --- conservative management --- blood pressure --- eradication --- interferon-free regimen --- hepatitis C infection --- kidney transplant --- allograft steatosis --- lipopeliosis --- transplant numbers --- live donors --- public awareness --- Google TrendsTM --- machine learning --- big data --- nephrology --- chronic kidney disease --- NLR --- PLR --- RPGN --- predictive value --- hemodialysis --- withdrawal --- cellular crescent --- global sclerosis --- procurement kidney biopsy --- glomerulosclerosis --- minimally-invasive donor nephrectomy --- robot-assisted surgery --- laparoscopic surgery --- organ donation --- living kidney donation --- MeltDose® --- LCPT --- renal function --- liver transplantation --- metabolism --- erythropoietin --- fibroblast growth factor 23 --- death --- weekend effect --- in-hospital mortality --- comorbidity --- dialysis --- elderly --- klotho --- α-Klotho --- FGF-23 --- kidney donor --- Nephrology --- CKD-MBD --- CKD-Mineral and Bone Disorder --- deceased donor --- Eurotransplant Senior Program --- risk stratification --- intensive care --- kidney transplant recipients --- long-term outcomes --- graft failure --- cardiovascular mortality --- lifestyle --- inflammation --- vascular calcification --- bone mineral density --- dual-energy X-ray absorptiometry --- living donation --- repeated kidney transplantation --- graft survival --- prolonged ischaemic time --- patient survival --- pre-emptive transplantation --- metabolomics --- urine --- acute rejection --- allograft --- cystatin C --- hyperfiltration --- kidney injury molecule (KIM)-1 --- tubular damage --- genetic polymorphisms --- (cardiac) surgery --- inflammatory cytokines --- clinical studies --- chronic kidney disease (CKD) --- no known kidney disease (NKD) --- ICD-10 billing codes --- phenotyping --- electronic health record (EHR) --- estimated glomerular filtration rate (eGFR) --- machine learning (ML) --- generalized linear model network (GLMnet) --- random forest (RF) --- artificial neural network (ANN), clinical natural language processing (clinical NLP) --- discharge summaries --- laboratory values --- area under the receiver operating characteristic (AUROC) --- area under the precision-recall curve (AUCPR) --- fibrosis --- extracellular matrix --- collagen type VI --- living-donor kidney transplantation --- ethnic disparity
Choose an application
In recent years, artificial intelligence has increasingly been playing an essential role in diverse areas in medicine, assisting clinicians in patient management. In nephrology and transplantation, artificial intelligence can be utilized to enhance clinical care, such as through hemodialysis prescriptions and the follow-up of kidney transplant patients. Furthermore, there are rapidly expanding applications and validations of comprehensive, computerized medical records and related databases, including national registries, health insurance, and drug prescriptions. For this Special Issue, we made a call to action to stimulate researchers and clinicians to submit their invaluable works and present, here, a collection of articles covering original clinical research (single- or multi-center), database studies from registries, meta-analyses, and artificial intelligence research in nephrology including acute kidney injury, electrolytes and acid–base, chronic kidney disease, glomerular disease, dialysis, and transplantation that will provide additional knowledge and skills in the field of nephrology and transplantation toward improving patient outcomes.
tacrolimus --- C/D ratio --- tacrolimus metabolism --- everolimus --- conversion --- kidney transplantation --- gut microbiome --- renal transplant recipient --- diarrhea --- immunosuppressive medication --- gut microbiota --- 16S rRNA sequencing --- butyrate-producing bacteria --- Proteobacteria --- torquetenovirus --- immunosuppression --- transplantation --- immunosuppressed host --- outcome --- renal transplantation --- Goodpasture syndrome --- anti-GBM disease --- epidemiology --- hospitalization --- outcomes --- acute kidney injury --- risk prediction --- artificial intelligence --- patent ductus arteriosus --- conservative management --- blood pressure --- eradication --- interferon-free regimen --- hepatitis C infection --- kidney transplant --- allograft steatosis --- lipopeliosis --- transplant numbers --- live donors --- public awareness --- Google TrendsTM --- machine learning --- big data --- nephrology --- chronic kidney disease --- NLR --- PLR --- RPGN --- predictive value --- hemodialysis --- withdrawal --- cellular crescent --- global sclerosis --- procurement kidney biopsy --- glomerulosclerosis --- minimally-invasive donor nephrectomy --- robot-assisted surgery --- laparoscopic surgery --- organ donation --- living kidney donation --- MeltDose® --- LCPT --- renal function --- liver transplantation --- metabolism --- erythropoietin --- fibroblast growth factor 23 --- death --- weekend effect --- in-hospital mortality --- comorbidity --- dialysis --- elderly --- klotho --- α-Klotho --- FGF-23 --- kidney donor --- Nephrology --- CKD-MBD --- CKD-Mineral and Bone Disorder --- deceased donor --- Eurotransplant Senior Program --- risk stratification --- intensive care --- kidney transplant recipients --- long-term outcomes --- graft failure --- cardiovascular mortality --- lifestyle --- inflammation --- vascular calcification --- bone mineral density --- dual-energy X-ray absorptiometry --- living donation --- repeated kidney transplantation --- graft survival --- prolonged ischaemic time --- patient survival --- pre-emptive transplantation --- metabolomics --- urine --- acute rejection --- allograft --- cystatin C --- hyperfiltration --- kidney injury molecule (KIM)-1 --- tubular damage --- genetic polymorphisms --- (cardiac) surgery --- inflammatory cytokines --- clinical studies --- chronic kidney disease (CKD) --- no known kidney disease (NKD) --- ICD-10 billing codes --- phenotyping --- electronic health record (EHR) --- estimated glomerular filtration rate (eGFR) --- machine learning (ML) --- generalized linear model network (GLMnet) --- random forest (RF) --- artificial neural network (ANN), clinical natural language processing (clinical NLP) --- discharge summaries --- laboratory values --- area under the receiver operating characteristic (AUROC) --- area under the precision-recall curve (AUCPR) --- fibrosis --- extracellular matrix --- collagen type VI --- living-donor kidney transplantation --- ethnic disparity
Choose an application
There is unequivocal experimental, epidemiological, and clinical evidence demonstrating a correlation between diet and increased risk of cardiovascular disease (CVD). While nutritionally-poor diets can have a significant negative impact on cardiovascular health, dietary interventions with specific nutrients and/or functional foods are considered cost-effective and efficient components of prevention strategies. It has been estimated that nutritional factors may be responsible for approximately 40% of all CVD. Indeed, in one of the seminal studies conducted on modifiable risk factors and heart health (the INTERHEART study), >90% of all myocardial infarctions were attributed to preventable environmental factors with nutrition identified as one of the important determinants of CVD. There is an increasing public interest in and scientific investigation into establishing dietary approaches that can be undertaken for the prevention and treatment of CVD. This Special Issue provides an insight into the influential role of nutrition and dietary habits on cardiovascular health and disease, as well as their mechanisms of therapeutic and preventive action.
Research & information: general --- Biology, life sciences --- Food & society --- magnesium deficiency --- arterial hypertension --- vascular tone --- arterial stiffness --- vascular remodeling --- insulin resistance --- magnesium supplementation --- dietary magnesium intake --- Zeb2 --- cardiac fibroblast --- activated myofibroblast --- cardiac fibrosis --- fibroblast contractility --- fish oil --- omega-3 fatty acids --- eicosapentaenoic acid (EPA) --- docosahexaenoic acid (DHA) --- cardiovascular disease --- irisin --- pediatric --- children --- nutrition --- diet --- body composition --- metabolic syndrome --- obesity, neonates --- Mediterranean diet --- inflammation --- nutrients --- polyphenols --- MUFA --- PUFA --- bioactive compounds --- phytosterols --- dietary pattern --- Aronia melanocarpa --- standardized extract --- dietary strategies --- supplementation --- cocaine --- cardiovascular health --- heart disease --- acute effects --- chronic effects --- marinobufagenin --- ouabain --- salt --- hypertension --- fibrosis --- Panax quinquefolius --- ginseng berry --- myocardial infarction --- phenolic compounds --- vascular aging --- vascular calcification --- arteriosclerosis --- Klotho --- chronic kidney disease (CKD), cancer --- diabetes --- heart failure --- micronutrients --- iron --- vitamins --- trace elements --- vitamin D --- seasonal variation --- lifestyle --- cytokines --- lipids --- mechanisms --- immunoregulatory --- eicosapentaenoic acid --- docosahexaenoic acid --- omega-3 polyunsaturated fatty acids --- coronary heart disease --- stretching --- TGF-β1 --- magnesium deficiency --- arterial hypertension --- vascular tone --- arterial stiffness --- vascular remodeling --- insulin resistance --- magnesium supplementation --- dietary magnesium intake --- Zeb2 --- cardiac fibroblast --- activated myofibroblast --- cardiac fibrosis --- fibroblast contractility --- fish oil --- omega-3 fatty acids --- eicosapentaenoic acid (EPA) --- docosahexaenoic acid (DHA) --- cardiovascular disease --- irisin --- pediatric --- children --- nutrition --- diet --- body composition --- metabolic syndrome --- obesity, neonates --- Mediterranean diet --- inflammation --- nutrients --- polyphenols --- MUFA --- PUFA --- bioactive compounds --- phytosterols --- dietary pattern --- Aronia melanocarpa --- standardized extract --- dietary strategies --- supplementation --- cocaine --- cardiovascular health --- heart disease --- acute effects --- chronic effects --- marinobufagenin --- ouabain --- salt --- hypertension --- fibrosis --- Panax quinquefolius --- ginseng berry --- myocardial infarction --- phenolic compounds --- vascular aging --- vascular calcification --- arteriosclerosis --- Klotho --- chronic kidney disease (CKD), cancer --- diabetes --- heart failure --- micronutrients --- iron --- vitamins --- trace elements --- vitamin D --- seasonal variation --- lifestyle --- cytokines --- lipids --- mechanisms --- immunoregulatory --- eicosapentaenoic acid --- docosahexaenoic acid --- omega-3 polyunsaturated fatty acids --- coronary heart disease --- stretching --- TGF-β1
Listing 1 - 10 of 11 | << page >> |
Sort by
|